4//SEC Filing
Gordon Gary B. 4
Accession 0000899243-22-018134
CIK 0001797336other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:10 PM ET
Size
4.8 KB
Accession
0000899243-22-018134
Insider Transaction Report
Form 4
Gordon Gary B.
Chief Medical Officer
Transactions
- Award
Common Stock
2022-05-16+50,000→ 58,520 total
Footnotes (1)
- [F1]Represents an award of restricted common stock, which will vest quarterly over a period of three years from May 16, 2022.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001811354
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:10 PM ET
- Size
- 4.8 KB